Delivery Order SPE2DB25D3109-SPE2DB25FPKWK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) with a contract ceiling value of $11,028.36. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The order is scheduled for ultimate completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of INGREZZA 80 MG capsules (30-count units) under a firm fixed-price contract with a ceiling value of $8,055.40 and an ultimate completion date of October 17, 2025. This non-set-aside, competitively awarded delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of INGREZZA 80 MG capsules (30-count units) with a ceiling value of $8,055.40. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,049.61 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of INGREZZA 60 mg capsules (30-count units). This is a firm fixed price delivery order with no set-aside designation, issued competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies a completion date of June 17, 2025, and identifies AmerisourceBergen's Corporate Office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units) with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The contractor will perform under this order at its corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 mg capsules (30-count units) under a firm fixed price contract. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 7, 2025, for INGREZZA 40 mg capsules (30-count units) with a ceiling value of $3,676.12. This competitively awarded, non-set-aside contract operates under a firm fixed-price model with an ultimate completion date of July 28, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 14, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for $8,055.40 on August 21, 2025, for the supply of Ingrezza 80 mg capsules (30-count units). The contract represents a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is...
- SPE2DB25D3109Indefinite Delivery Contract
- SPE2DB25D3109-SPE2DB25FPKWKDelivery Order
The Defense Logistics Agency awarded a $7,352.24 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of INGREZZA 40 mg capsules (30-count units). This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and related supplies across multiple therapeutic domains. The company serves customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 7/29/25 |